Mulhern B, Rowen D, Jacoby A, Marson T, Snape D, Hughes D, Latimer N, Baker GA & Brazier JE (2012) The development of a QALY measure for epilepsy: NEWQOL-6D. Epilepsy and Behavior.
Kowalski JW, Rentz AM, Walt JG, Lloyd A, Lee J, Young TA, Chen W-H, Bressler NM, Lee P, Brazier JE, Hays RD & Revicki DA (2011) Rasch analysis in the development of a simplified version of the national eye institute visual-function questionnaire-25 for utility estimation. Quality of Life Research, 1-12.
Ratcliffe J, Stevens K, Flynn T, Brazier J & Sawyer M (2011) An assessment of the construct validity of the CHU9D in the Australian adolescent general population. Quality of Life Research, 1-9.
Brazier J, Rowen D, Yang Y & Tsuchiya A (2011) Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale. European Journal of Health Economics, 1-13.
McGhee SM, Wong LC, Chau J, Cheung A, Ho A, Lam CLK & Brazier J (2011) Quality-adjusted life years: Population-specific measurement of the quality component. Hong Kong Medical Journal, 17(6 SUPPL 6), 17-21.
Rowen D, Carlton J, Brazier JE, Mulhern B, Palfreyman S, Stevens K & Tsuchiya A (2010) FDA on PROMs: Two important points. BMJ (Online), 341(7776), 746-746.
Tilling CJ, Krol M, Tsuchiya A, Brazier JE & Brouwer W (2008) IN OR OUT? EMPIRICAL EVIDENCE ON INCOME LOSSES IN HEALTH STATE VALUATIONS AND IMPLICATIONS FOR ECONOMIC EVALUATIONS. VALUE HEALTH, 11(6), A563-A564.
Karnon J, Goyder E, Tappenden P, McPhie S, Towers I, Brazier J & Madan J (2007) A review and critique of modelling in prioritising and designing screening programmes. HEALTH TECHNOL ASSES, 11(52), 1-+.
Karnon J, Goyder E, Tappenden P, McPhie S, Towers I, Brazier J & Madan J (2007) A review and critique of modelling in prioritising and designing screening programmes.. Health technology assessment (Winchester, England), 11(52).
Michaels JA, Campbell WB, Brazier JE, Macintyre JB, Palfreyman SJ, Ratcliffe J & Rigby K (2006) Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial).. Health Technol Assess, 10(13), 1-iv.
Michales JA, Campbell WB, Brazier JE, MacIntyre JB, Palfreyman SJ, Ratcliffe J & Rigby K (2006) Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial). HEALTH TECHNOL ASSES, 10(13), III-+.
Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverley C, Parry G, Rooney G & Sutcliffe P (2006) Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation.. Health Technol Assess, 10(33), iii-168.
Brazier J, Tumur I, Holmes M, Ferriter M, Parry G, Dent-Brown K & Paisley S (2006) Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation.. Health Technol Assess, 10(35), iii-117.
McCabe CJ, Stevens KJ & Brazier JE (2005) Utility scores for the Health Utilities Index Mark 2: an empirical assessment of alternative mapping functions.. Med Care, 43(6), 627-635.
Walters SJ & Brazier JE (2005) Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.. Qual Life Res, 14(6), 1523-1532.
Stevenson MD, Brazier JE, Calvert NW, Lloyd-Jones M, Oakley JE & Kanis JA (2005) Description of an individual patient methodology for calculating the cost-effectiveness of treatments for osteoporosis in women. J OPER RES SOC, 56(2), 214-221.
Kharroubi SA, O'Hagan A & Brazier JE (2005) Estimating utilities from individual health preference data: a nonparametric Bayesian method. J ROY STAT SOC C-APP, 54, 879-895.
Thomas KJ, MacPherson H, Ratcliffe J, Thorpe L, Brazier J, Campbell M, Fitter M, Roman M, Walters S & Nicholl JP (2005) Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.. Health Technol Assess, 9(32), iii-109.
Brazier J, Akehurst R, Brennan A, Dolan P, Claxton K, McCabe C, Sculpher M & Tsuchyia A (2005) Should patients have a greater role in valuing health states?. Appl Health Econ Health Policy, 4(4), 201-208.
Thomas KJ, MacPherson H, Ratcliffe J, Thorpe L, Brazier J, Campbell M, Fitter M, Roman M, Walters S & Nicholl JP (2005) Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.. Health technology assessment (Winchester, England), 9(32).
Hibbert CL, Coates EJ, Brazier JE & Morris J (2005) A cost survey of 70 adult critical care units - Results from a volunteer sample in England, Scotland and Northern Ireland in 2003. Care of the Critically Ill, 21(1), 8-17.
Hatoum HT, Brazier JE & Akhras KS (2004) Comparison of the HUI3 with the SF-36 preference based SF-6D in a clinical trial setting. VALUE HEALTH, 7(5), 602-609.
Wailoo A, Roberts J, Brazier J & McCabe C (2004) Efficiency, equity, and NICE clinical guidelines - Clinical guidelines need a broader view than just the clinical. BRIT MED J, 328(7439), 536-537.
Littlejohns P, Leng G, Culyer T, Drummond M, Pilling S, Dutchak J, McInnes E, Macbeth F, Pearson M, Thomas J, Turnbull N, Eccles M, Wailoo A, Roberts J, Brazier J & McCabe C (2004) NICE clinical guidelines [2] (multiple letters). British Medical Journal, 329(7465), 571-572.
Wailoo A, Roberts J, Brazier J & McCabe C (2004) Efficiency, equity, and NICE clinical guidelines. British Medical Journal, 328(7439), 536-537.
Walters SJ & Brazier JE (2003) What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D.. Health Qual Life Outcomes, 1, 4.
Akehurst RL, Brazier JE, Mathers N, O'Keefe C, Kaltenthaler E, Morgan A, Platts M & Walters SJ (2002) Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting.. Pharmacoeconomics, 20(7), 455-462.
Kanis JA, Brazier JE, Stevenson M, Calvert NW & Lloyd Jones M (2002) Treatment of established osteoporosis: a systematic review and cost-utility analysis.. Health Technol Assess, 6(29), 1-146.
Brazier J, Roberts J & Deverill M (2002) The estimation of a preference-based measure of health from the SF-36.. J Health Econ, 21(2), 271-292.
Brazier J & Fitzpatrick R (2002) Measures of health-related quality of life in an imperfect world: a comment on Dowie.. Health Econ, 11(1), 17-19.
Robinson J, Brazier J & Beard J (2002) Patient-determined quality of life measure in critical limb ischaemia. BRIT J SURG, 89(4), 526-526.
Schackman BR, Goldie SJ, Freedberg KA, Losina E, Brazier J & Weinstein MC (2002) Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS. MED DECIS MAKING, 22(1), 27-38.
Kanis JA, Brazier JE, Stevenson M, Calvert NW & Jones ML (2002) Treatment of established osteoporosis: A systematic review and cost-utility analysis. Health Technology Assessment, 6(29).
Walters SJ, Munro JF & Brazier JE (2001) Using the SF-36 with older adults: a cross-sectional community-based survey.. Age Ageing, 30(4), 337-343.
Brazier JE & Johnson AG (2001) Economics of surgery.. Lancet, 358(9287), 1077-1081.
Brazier JE & Johnson AG (2001) Economics of surgery. Lancet, 358(9287), 1077-1081.
Cotton L, Brazier J, Hall DM, Lindsay G, Marsh P, Polnay L & Williams TS (2000) School nursing: costs and potential benefits.. J Adv Nurs, 31(5), 1063-1071.
Michaels J, Brazier J, Palfreyman S, Shackley P & Slack R (2000) Cost and outcome implications of the organisation of vascular services.. Health Technol Assess, 4(11), i-191.
Green C, Brazier J & Deverill M (2000) Valuing health-related quality of life. A review of health state valuation techniques.. Pharmacoeconomics, 17(2), 151-165.
Morgan A, Shackley P, Pickin M & Brazier J (2000) Quantifying patient preferences for out-of-hours primary care.. J Health Serv Res Policy, 5(4), 214-218.
Michaels J, Brazier J, Palfreyman S, Shackley P & Slack R (2000) Cost and outcome implications of the organisation of vascular services. Health Technology Assessment, 4(11).
Brazier JE, Harper R, Munro J, Walters SJ & Snaith ML (1999) Generic and condition-specific outcome measures for people with osteoarthritis of the knee.. Rheumatology (Oxford), 38(9), 870-877.
Brazier J, Deverill M, Green C, Harper R & Booth A (1999) A review of the use of health status measures in economic evaluation.. Health Technol Assess, 3(9), i-164.
Thomas KJ, Fitter M, Brazier J, MacPherson H, Campbell M, Nicholl JP & Roman M (1999) Longer-term clinical and economic benefits of offering acupuncture to patients with chronic low back pain assessed as suitable for primary care management.. Complement Ther Med, 7(2), 91-100.
Dixon S, Deverill M, Gannon M, Brazier J & Haggard M (1999) Improving the validity of economic evaluations alongside controlled trials.. J Health Serv Res Policy, 4(3), 161-163.
Brazier J & Deverill M (1999) A checklist for judging preference-based measures of health related quality of life: learning from psychometrics.. Health Econ, 8(1), 41-51.
Brazier J, Deverill M & Green C (1999) A review of the use of health status measures in economic evaluation.. J Health Serv Res Policy, 4(3), 174-184.
Brazier J, Deverill M, Green C, Harper R & Booth A (1999) A review of the use of health status measures in economic evaluation. Health Technology Assessment, 3(9).
Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L & Sullivan M (1998) Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1171-1178.
Raczek AE, Ware JE, Bjorner JB, Gandek B, Haley SM, Aaronson NK, Apolone G, Bech P, Brazier JE, Bullinger M & Sullivan M (1998) Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1203-1214.
Deverill M, Brazier J, Green C & Booth A (1998) The use of QALY and non-QALY measures of health-related quality of life. Assessing the state of the art.. Pharmacoeconomics, 13(4), 411-420.
Wight JP, Edwards L, Brazier J, Walters S, Payne JN & Brown CB (1998) The SF36 as an outcome measure of services for end stage renal failure.. Qual Health Care, 7(4), 209-221.
Brazier J, Usherwood T, Harper R & Thomas K (1998) Deriving a preference-based single index from the UK SF-36 Health Survey.. J Clin Epidemiol, 51(11), 1115-1128.
Keller SD, Ware JE, Gandek B, Aaronson NK, Alonso J, Apolone G, Bjorner JB, Brazier J, Bullinger M, Fukuhara S, Kaasa S, Leplege A, Sanson-Fisher RW, Sullivan M & Wood-Dauphinee S (1998) Testing the equivalence of translations of widely used response choice labels: Results from the IQOLA project. J CLIN EPIDEMIOL, 51(11), 933-944.
Gandek B, Ware JE, Aaronson NK, Alonso J, Apolone G, Bjorner J, Brazier J, Bullinger M, Fukuhara S, Kaasa S, Leplege A & Sullivan M (1998) Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1149-1158.
Ware JE, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L & Sullivan M (1998) The factor structure of the SF-36 Health Survey in 10 countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1159-1165.
Ware JE, Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M & Thunedborg K (1998) The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1167-1170.
Keller SD, Ware JE, Bentler PM, Aaronson NK, Alonso J, Apolone G, Bjorner JB, Brazier J, Bullinger M, Kaasa S, Leplege A, Sullivan M & Gandek B (1998) Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: Results from the IQOLA Project. J CLIN EPIDEMIOL, 51(11), 1179-1188.
Harper R, Brazier JE, Waterhouse JC, Walters SJ, Jones NM & Howard P (1997) Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting.. Thorax, 52(10), 879-887.
Munro J, Brazier J, Davey R & Nicholl J (1997) Physical activity for the over-65s: could it be a cost-effective exercise for the NHS?. J Public Health Med, 19(4), 397-402.
Snooks HA, Nicholl JP, Brazier JE & Lees-Mlanga S (1996) The costs and benefits of helicopter emergency ambulance services in England and Wales.. J Public Health Med, 18(1), 67-77.
Brazier JE, Walters SJ, Nicholl JP & Kohler B (1996) Using the SF-36 and Euroqol on an elderly population.. Qual Life Res, 5(2), 195-204.
McCabe CJ, Thomas KJ, Brazier JE & Coleman P (1996) Measuring the mental health status of a population: A comparison of the GHQ-12 and the SF-36 (MHI-5). BRIT J PSYCHIAT, 169(4), 517-521.
Brazier J, Nicholl J & Snooks H (1996) The cost and effectiveness of the London Helicopter Emergency Medical Service.. J Health Serv Res Policy, 1(4), 232-237.
Alexander W, Bradley C, Brazier J, Campbell K, Chadwick J, Clements D, Hall G, Mackinnon M, McLeod C, Miles K, Roberts S, Ruffel A & White A (1996) The report of the Clinical Care Group. Diabetic Medicine, 13(SUPPL. 4).
Nicholl JP, Brazier JE & Snooks HA (1995) Effects of London helicopter emergency medical service on survival after trauma.. BMJ, 311(6999), 217-222.
WARE JE, KELLER SD, GANDEK B, BRAZIER JE & SULLIVAN M (1995) EVALUATING TRANSLATIONS OF HEALTH-STATUS QUESTIONNAIRES - METHODS FROM THE IQOLA PROJECT. INT J TECHNOL ASSESS, 11(3), 525-551.
Brazier J & Dixon S (1995) The use of condition specific outcome measures in economic appraisal.. Health Econ, 4(4), 255-264.
Brazier J (1995) The Short-Form 36 (SF-36) Health Survey and its use in pharmacoeconomic evaluation.. Pharmacoeconomics, 7(5), 403-415.
BOWLING A & BRAZIER J (1995) INTRODUCTION - QUALITY-OF-LIFE IN SOCIAL-SCIENCE AND MEDICINE. SOC SCI MED, 41(10), 1337-1338.
Nicholl JP, Coleman P & Brazier JE (1994) Health and healthcare costs and benefits of exercise.. Pharmacoeconomics, 5(2), 109-122.
Nicholl JP, Ross B, Milner PC, Brazier JE, Westlake L, Kohler B, Frost E, Williams BT & Johnson AG (1994) Cost effectiveness of adjuvant bile salt treatment in extracorporeal shock wave lithotripsy for the treatment of gall bladder stones.. Gut, 35(9), 1294-1300.
Nicholl JP, Beeby NR & Brazier JE (1994) A comparison of the costs and performance of an emergency helicopter and land ambulances in a rural area.. Injury, 25(3), 145-153.
Lowy A, Brazier J, Fall M, Thomas K, Jones N & Williams BT (1994) Quality of minor surgery by general practitioners in 1990 and 1991.. Br J Gen Pract, 44(385), 364-365.
WARE JE, GANDEK B, AARONSON NK, ACQUADRO C, ALONSO J, APOLONE G, BECH P, BRAZIER J, BULLINGER M, FUKUHARA S, KAASA S, KELLER S, LEPLEGE A, RAZAVI D, SANSONFISHER R, SULLIVAN M, WAGNER A & WOODDAUPHINEE S (1994) THE SF-36 HEALTH SURVEY - DEVELOPMENT AND USE IN MENTAL-HEALTH RESEARCH AND THE IQOLA PROJECT. INT J MENT HEALTH, 23(2), 49-73.
Nicholl JP, Milner PC, Brazier JE, Westlake L, Kohler B, Williams BT, Ross B, Frost E & Johnson AG (1994) Cost effectiveness of adjuvant bile salt treatment in extracorporeal shock wave lithotripsy for the treatment of gall bladder stones. Gut, 35(9), 1294-1300.
Brazier J (1993) The SF-36 health survey questionnaire--a tool for economists.. Health Econ, 2(3), 213-215.
Lowy A, Brazier J, Fall M, Thomas K, Jones N & Williams BT (1993) Minor surgery by general practitioners under the 1990 contract: effects on hospital workload.. BMJ, 307(6901), 413-417.
Brazier J, Jones N & Kind P (1993) Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire.. Qual Life Res, 2(3), 169-180.
Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T & Westlake L (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care.. BMJ, 305(6846), 160-164.
Nicholl JP, Brazier JE, Milner PC, Westlake L, Kohler B, Williams BT, Ross B, Frost E & Johnson AG (1992) Randomised controlled trial of cost-effectiveness of lithotripsy and open cholecystectomy as treatments for gallbladder stones.. Lancet, 340(8823), 801-807.
Triger DR, Johnson AG, Brazier JE, Johnston GW, Spencer EF, McKee R, Anderson JR & Carter DC (1992) A prospective trial of endoscopic sclerotherapy v oesophageal transection and gastric devascularisation in the long term management of bleeding oesophageal varices.. Gut, 33(11), 1553-1558.
O'Cathain A, Brazier JE, Milner PC & Fall M (1992) Cost effectiveness of minor surgery in general practice: a prospective comparison with hospital practice.. Br J Gen Pract, 42(354), 13-17.
Triger DR, Johnson AG, Brazier JE, Johnston GW, Spencer EFA, McKee R, Anderson JR & Carter DC (1992) A prospective trial of endoscopic sclerotherapy v oesophageal transection and gastric devascularisation in the long term management of bleeding oesophageal varices. Gut, 33(11), 1553-1558.
BRAZIER JE & NORMAND CEM (1991) AN ECONOMIC-REVIEW OF THE NHS WHITE PAPER. SCOT J POLIT ECON, 38(1), 96-105.
Page H & Brazier J (1991) The funding debate revisited: who's for the mixed economy?. Health Serv Manage, 87(2), 84-86.
George S & Brazier J (1991) Information needs in a provider market: a case-study of ENT.. J Public Health Med, 13(2), 108-114.
Milner PC, Brazier JE, Nicholl JP, Ross B & Johnson AG (1989) Evaluating gallbladder lithotripsy. Lancet, 2(8653), 51-51.
Bevan G & Brazier J (1987) Financial incentives of subregional RAWP.. Br Med J (Clin Res Ed), 295(6602), 836-838.
Brazier J (1987) Accounting for cross boundary flows.. Br Med J (Clin Res Ed), 295(6603), 898-900.
Chapters
Brazier JE (2009) SF-6D In Kattan MW & Cowen ME (Ed.), Encyclopaedia of Medical Decision Making California: Sage Publications.
Brazier JE & Ratcliffe J (2008) The measurement and Valuation of Health for Economic Evaluation. In Heggenhougen HK & Quah S (Ed.), International Encyclopaedia of Public Health. (pp. 252-261). San Diego: Academic Press.
Brazier JE & Roberts J (2007) Methods for developing preference-based measures of Health. In Jones A (Ed.), The Elgar Companion to Health Economics (pp. 371-381). Cheltenham UK: Edward Elgar Publishing Ltd.
Brazier JE & Morgan A (2002) Economic evaluation of complementary therapies, Clinical Research in complementary therapies London: Churchill Livingstone.
Brazier JE, Rice N & Roberts J (2002) Modelling health state valuation data In Murray C, Saloman J, Mathers C & Lopez A (Ed.), Summary Measures of Population Health 2002: Concepts, Ethics, Measurement and Applications (pp. 529-548). World Health Organisation.
Brazier JE, Deverill M & Green C (2001) The use of health related quality of life questionnaires in economic evaluation. In Stevens A, Abrams K, Brazier J, Fitzpatrick R & Lilford R (Ed.), Methods in Hdealth Technology Assessment London: Sage Books.
Brazier JE, Green G, Ormandy D & Gilbertson J (2000) Tolerant Building: The impact of energy efficiency measures on living conditions and health status. In Rudge J & Nical F (Ed.), Cutting the cost of cold: Affordable warmth for healthier homes London: Spon Press.
Brazier JE, Green G, Ormandy D & Gilbertson J (2000) Tolerant Building: The impact of energy efficiency measures on living conditions and health status In Rudge J & Nical F (Ed.), Cutting the cost of cold: Affordable warmth for healthier homes (pp. 87-106). London: Taylor & Francis.
Brazier JE & Deverill M (1998) The use of health related quality of life questionnaires in economic evaluation. In Black N, Fitzpatrick R & Reeves B (Ed.), Methods for Health Services Research: a state of the art guide. London: BMJ Books.
Brazier JE (1998) The SF-36 Health Survey and its use in Pharmacoeconomics economic evaluation., Quality of Life Assessment Auckland: Adis International.
Brazier JE & Cairns J (1996) An economic perspective on health outcome measurement. In Hutchinson & et al (Ed.), Outcome Measurement in Primary Care Amsterdam: Harwood academic publishers.
Brazier JE & Green C (1996) Economic Evaluation in Brief In Earlam RJ (Ed.), The Royal Hospital Trauma Hospital - A Trauma Care System London.
Brazier JE, Williams BT & Nicholl J (1996) Health Care Needs Assessment: Accident and Emergency Departments. In Stevens A & Raftery J (Ed.), Health Care Needs Assessment Frome: Radlcliffe Medical Press.
Brazier JE & Jeavons R (1991) The economics of diabetic care In Bradley C, Christine M & West R (Ed.), The technology of diabetic care London: Harwood.
Brazier JE, Hutton J & Jeavons R (1990) Evaluating the reform of the NHS In Culyer AJ, Maynard A & Posnett J (Ed.), Competition in Health Care: reforming the NHS London: MacMillan Press.
Brazier JE, Jeavons R & Akehurst R (1989) The White Paper and the NHS: How much competition will there actually be?, Health Care UK Newbury: Policy Journals.
Brazier JE (1988) District health authorities as trading organisations., Health Care UK Newbury: Policy Journals.
Conferences
Norman R, Viney R, Brazier J, Burgess L, Cronin P, King M, Ratcliffe J & Street DJ (2012) USING DISCRETE CHOICE EXPERIMENTS TO VALUE HEALTH STATES FOR ECONOMIC EVALUATION - THE SF-6D IN AUSTRALIA. VALUE IN HEALTH, 15(7), A605-A606.
Palfreyman S & Brazier J (2012) THE DEVELOPMENT AND VALUATION OF THE SHEFFIELD PREFERENCE BASED LEG ULCER QUESTIONNAIRE (SPVU-5D). VALUE IN HEALTH, 15(4), A126-A126.
King M, Costa DSJ, Aaronson NK, Brazier J, Cella DF, Fayers P, Pallant JF, Peacock S, Pickard AS, Rowen D, Velikova G & Young T (2012) THE DEVELOPMENT OF AN INTERNATIONALLY-VALID CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENT (MAUI) FROM THE EORTC CORE HEALTH-RELATED QUALITY OF LIFE (HRQOL) QUESTIONNAIRE, QLQ-C30. VALUE IN HEALTH, 15(4), A225-A225.
King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella D, Fayers PM, Pallant JF, Peacock S, Pickard S, Rowen D, Velikova G, Young T & Consortium M (2012) THE DEVELOPMENT OF AN INTERNATIONALLY-VALID CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENT (MAUI) FROM THE EORTC CORE HEALTH-RELATED QUALITY OF LIFE (HRQOL) QUESTIONNAIRE, QLQ-C30. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 8, 335-335.
Papaioannou D, Peasgood T, Brazier J & Parry G (2011) THE VALIDITY OF THE EQ-5D, SF-6D, SF-36 AND SF-12 IN MENTAL HEALTH CONDITIONS: A SYSTEMATIC REVIEW. VALUE IN HEALTH, 14(7), A239-A239.
Meadows K, Mulhern B, Rowen D & Brazier J (2011) MAPPING THE DIABETES HEALTH PROFILE (DHP-18) ONTO THE EQ-5D AND SF-6D GENERIC PREFERENCE BASED MEASURES OF HEALTH. VALUE IN HEALTH, 14(7), A242-A242.
Brazier J, Rowen D, Tsuchiya A, Young T & Ibbotson R (2011) THE IMPACT OF CONDITION LABELLING ON HEALTH STATE VALUES. VALUE IN HEALTH, 14(7), A457-A457.
Peasgood T, Ward SE & Brazier J (2011) HEALTH STATE UTILITY VALUES IN BREAST CANCER: A REVIEW AND META-ANALYSIS. VALUE IN HEALTH, 14(7), A462-A462.
Ara R & Brazier J (2011) ESTIMATING SF-6D HEALTH STATE UTILITY VALUES FOR COMORID HEALTH CONDITIONS. VALUE IN HEALTH, 14(7), A427-A427.
Ara R & Brazier J (2011) ARE GENERAL POPULATION DATA SUITABLE FOR APPROXIMATING BASELINE UTILITY VALUES IN ECONOMIC MODELS?. VALUE IN HEALTH, 14(7), A428-A428.
Mutebi A, Brazier J & Walters S (2010) A COMPARISON OF THE DISCRIMINTATIVE AND EVALUATIVE PROPERTIES OF THE SF-36 AND THE SF-6D INDEX. VALUE HEALTH, 13(3), A17-A17.
Ara R & Brazier J (2010) ESTIMATING HEALTH STATE UTILITY VALUES FOR COMORBID HEALTH CONDITIONS. VALUE HEALTH, 13(7), A334-A335.
Cruz LN, Camey SA, Hoffmann JF, Brazier J, Rowen D, Fleck MP & Polanczyk CA (2010) ESTIMATING THE SF-6D VALUE SET FOR A POPULATION BASED SAMPLE OF BRAZILIANS. VALUE HEALTH, 13(7), A240-A240.
McTaggart-Cowan HM, Tsuchiya A, O'Cathain A & Brazier JE (2009) THE IMPACT OF DISEASE ADAPTATION ON GENERAL POPULATION VALUES. VALUE HEALTH, 12(3), A35-A35.
Schwenkglenks M, Szucs TD, Brazier JE, Blackman DJ, Cyr P, Olchanski N & Stone GW (2009) COST-EFFECTIVENESS OF BIVALIRUDIN VERSUS HEPARIN PLUS GLYCOPROTEIN IIB/IIIA INHIBITOR IN THE TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION-A HORIZONS TRIAL ANALYSIS USING UK VALUATIONS. VALUE HEALTH, 12(7), A334-A335.
Szende A, Brazier J, Schaefer C, Deuson R, Isitt J & Vyas P (2009) MEASUREMENT OF HEALTH UTILITY VALUES IN THE UK FOR HEALTH STATES RELATED TO IMMUNE (IDIOPATHIC) THROMBOCYTOPENIC PURPURA (ITP). VALUE HEALTH, 12(7), A383-A383.
Ara R & Brazier JE (2008) Predicting SF-6D preference-based utilities using mean SF-36 health dimension scores when patient level data are not available. VALUE HEALTH, 11(3), A178-A178.
Ara R & Brazier JE (2008) Predicting a mean EQ-5D preference-based score from the 8 mean SF-36 dimension scores when individual data is not available. VALUE HEALTH, 11(3), A178-A179.
Brazier J, Tumur I, Holmes M, Ferriter M, Dent-Brown K, Paisley S & Parry G (2007) Psychological therapies for borderline personality disorder: A systematic review. J MENT HEALTH POLICY, 10, S5-S6.
Holmes M, Brazier J, Tumur I, Ferriter M, Parry G, Dent-Brown K & Paisley S (2007) A probabilistic cost-effectiveness analysis of psychological therapies including dialectical behaviour therapy for borderline personality disorder.. J MENT HEALTH POLICY, 10, S18-S19.
Burness CE, Howlett S, Brazier J, Grunewald RA & Reuber M (2007) Outcome of tailored psychotherapy for nonepileptic seizures and other functional neurological symptoms. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 78(9), 1016-1016.
Bansback N, Harrison M, Brazier J, Davies L, Kopec J, Marra C, Symmons D & Anis A (2007) Health state utility values in rheumatic diseases - A review. ANNALS OF THE RHEUMATIC DISEASES, 66, 256-256.
Reeves P & Brazier JE (2006) Estimating a preference-based index from a condition specific measure - The King's Health Questionnaire. VALUE HEALTH, 9(3), A97-A98.
Brazier JE, Yang Y, Tsuchiya A & Coyne K (2006) Estimating a preference-based single index from the Overactive Bladder Questionnaire. VALUE HEALTH, 9(3), A98-A98.
Ara RM & Brazier J (2006) Mapping generic quality of life measurements to disease specific variables in patients with Ankylosing Spondylitis. ANNALS OF THE RHEUMATIC DISEASES, 65, 273-273.
Palfreyman SJ, Michaels JA, Campbell WB, Brazier JE, MacIntyre JB, Ratcliffe J & Rigby K (2005) A prospective clinical trial of the management and outcome of uncomplicated varicose veins. BRITISH JOURNAL OF SURGERY, 92(4), 506-506.
Michaels JA, Campbell WB, Brazier JE, MacIntyre JB, Palfreyman SJ, Ratcliffe J & Rigby K (2005) Randomized trial of treatment for uncomplicated varicose veins: surgery is clinically and cost effective. BRITISH JOURNAL OF SURGERY, 92(4), 506-507.
Gray DT, Walters S, Spertus J, Brazier J & Horvath K (2005) Quality-adjusted survival and cost-effectiveness of transmyocardial revascularization using the CO2 laser. CIRCULATION, 111(20), E319-E319.
Stevenson MD, Lloyd-Jones M, Brazier JE, Calvert N, Oakley J & Kanis JA (2004) The cost-effectiveness of calcium and vitamin D supplementation in women with low dietary intake of these nutrients and at risk of osteoporosis. OSTEOPOROSIS INTERNATIONAL, 15, S87-S88.
Stevenson MD, Brazier JE, Lloyd-Jones M, Calvert N, Oakley J & Kanis JA (2004) The cost-effectiveness of bisphosphonates, raloxifene and hormone replacement therapy in women with established osteoporosis and replete of calcium and vitamin D. OSTEOPOROSIS INTERNATIONAL, 15, S111-S111.
Marra CA, Esdaile JM, Guh D, Kopec JA, Brazier JE, Koehler BE, Chalmers A & Anis AH (2004) A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. MEDICAL CARE, 42(11), 1125-1131.
Stevenson MD, Brazier JE, Calvert NW, Lloyd-Jones M, Oakley JE & Kanis JA (2004) The cost-effectiveness of bisphosphonates, raloxifene and teriparatide in women with a prior fracture, low BMD and replete of calcium and vitamin D. OSTEOPOROSIS INTERNATIONAL, 15, S39-S39.
Stevenson MD, Brazier JE, Calvert NW, Lloyd-Jones M, Oakley JE & Kanis JA (2004) The cost-effectiveness of calcium and vitamin D in women with low dietary calcium intake. OSTEOPOROSIS INTERNATIONAL, 15, S39-S40.
Ratcliffe J, Brazier J, Palfreyman S & Michaels J (2004) An exploration of the discrepancies between health state valuations of patients and the general population. VALUE HEALTH, 7(6), 775-775.
Smith S, Brazier JE, Parry G & Edbrooke DL (2003) SF-36 and EQ-5D in adult ICU patients. INTENSIVE CARE MEDICINE, 29, S176-S176.
Brazier JE, Zoellner YF, Platts M & Towers I (2003) Developing a preference-based measure for postmenopausal health. VALUE HEALTH, 6(6), 606-606.
McCloskey E, Jalava T, Oden A, Johansson H, Kayan K, Beneton M, Brazier J, Nicholl J, Richards A, Cliffe J, Reaney L, Nevalainen J & Kanis J (2003) The efficacy of clodronate (Bonefos (R)) to reduce the incidence of osteoporotic fractures in elderly women is independent of the underlying BMD.. JOURNAL OF BONE AND MINERAL RESEARCH, 18, S92-S92.
Fry AM, Round A, Stein K, Brazier J & Milne R (2003) Justifying the development of a lay panel to produce utilities for use in health technology assessments (HTAS): Review of current issues,and views of technology appraisal committee members. VALUE HEALTH, 6(3), 305-305.
Marra CA, Woolcott J, Shojania K, Brazier JE, Esdaile JM & Anis AH (2002) Comparison of health state utilities using community and patient preference weights derived from a survey of patients with rheumatoid arthritis.. ARTHRITIS AND RHEUMATISM, 46(9), S74-S74.
Marra CA, Woolcott J, Offer R, Guh D, Brazier JE, Esdaile JM & Anis AH (2002) A within subject comparison of four indirect utility measures in rheumatoid arthritis.. ARTHRITIS AND RHEUMATISM, 46(9), S74-S74.
Stevenson MD, Brazier JE, Kanis J & Lloyd-Jones M (2000) Cost-effectiveness of current treatments for established female osteoporosis. OSTEOPOROSIS INT, 11, S11-S11.
deTakats D, McCloskey E, Bernard J, Orgee J, Coombes G, Khan S, Nicholl J, Brazier J, Beneton M, Charlesworth D & Kanis J (1997) Effects of clodronate on hip BMD in community-dwelling women: Randomised trial: 1 year results.. J BONE MINER RES, 12, S490-S490.
MCCLOSKEY E, KHAN S, ORGEE J, COOMBES G, TAUBE T, PHILLIPS R, BRAZIER J, NICHOLL J & KANIS J (1995) ORAL CLODRONATE PREVENTS BONE LOSS AT THE HIP IN ELDERLY WOMEN - A PILOT-STUDY. J BONE MINER RES, 10, S356-S356.
AARONSON NK, ACQUADRO C, ALONSO J, APOLONE G, BECH P, BRAZIER J, BULLINGER M, FUKUHARA S, GANDEK B, KAASA S, KELLER S, WAGNER A, WARE JE, LEPLEGE A, RAZAVI D, SANSONFISHER R, SULLIVAN M & WOODDAUPHINEE S (1994) TRANSLATING HEALTH - THE INTERNATIONAL QUALITY-OF-LIFE ASSESSMENT (IQOLA) PROJECT. QUAL LIFE RES, 3(1), 66-66.
WARE JE, KELLER S, BENTLER PM, SULLIVAN M, BRAZIER J & GANDEK B (1994) COMPARISON OF HEALTH-STATUS MEASUREMENT MODELS AND THE VALIDITY OF SF-36 IN GREAT-BRITAIN, SWEDEN AND THE USA. QUAL LIFE RES, 3(1), 68-68.
Wailoo A, Roberts J, Brazier J & McCabe C (2004) NICE clinical guidelines - Health economics must engage with complexity of issues - Reply. BRIT MED J, 329(7465), 572-572.
Harper R, Brazier J & Waterhouse J (1998) Comparison of outcome measures in patients with COPD - Reply. THORAX, 53(9), 813-813.
NICHOLL J, SNOOKS H & BRAZIER J (1995) EFFECTS OF HELICOPTER SERVICE ON SURVIVAL AFTER TRAUMA - REPLY. BRIT MED J, 311(7013), 1166-1166.
BRAZIER J (1995) HEALTH-STATUS MEASUREMENT - A PERSPECTIVE ON CHANGE - BROOKS,RG. HEALTH ECON, 4(2), 149-150.
Nicholl JP & Brazier JE (1993) Laparoscopic versus mini-incision cholecystectomy.. Lancet, 341(8836), 47.
NICHOLL J, BRAZIER JE & WILLIAMS BT (1993) MANAGEMENT OF TRAUMA. BRIT MED J, 307(6905), 683-684.
LOWY A, FALL M & BRAZIER J (1993) SKIN BIOPSIES BY GPS. BRIT J GEN PRACT, 43(376), 478-478.
Nicholl J, Brazier JE & Williams BT (1993) Management of trauma [20]. British Medical Journal, 307(6905), 683-684.
BRAZIER J, HARPER R, JONES N, THOMAS K, WESTLAKE L & USHERWOOD T (1992) VALIDATING THE SF-36 - REPLY. BRIT MED J, 305(6854), 646-646.
BRAZIER JE & LOWY A (1991) PERFORMANCE OF SKIN BIOPSIES BY GENERAL-PRACTITIONERS. BRIT MED J, 303(6815), 1472-1472.
GEORGE SL & BRAZIER JE (1990) CASELOAD OR WORKLOAD. BRIT MED J, 301(6751), 556-556.
PITT FA & BRAZIER J (1990) HORMONE REPLACEMENT THERAPY FOR OSTEOPOROSIS. LANCET, 335(8695), 978-978.
Milner PC, Brazier JE, Nicholl JP, Ross B & Johnson AG (1989) Evaluating gallbladder lithotripsy.. Lancet, 2(8653), 51.
PAGE H & BRAZIER J (1989) BENEFITS OF INVITRO FERTILIZATION. LANCET, 2(8675), 1327-1328.
